Esculetin restores mitochondrial dysfunction and reduces allergic asthma features in experimental murine model

Journal of Immunology

Volumn 183, Issue 3, 2009, Pages 2059-2067

  Mabalirajan, Ulaganathan ^a,b   Dinda, Amit Kumar ^b   Sharma, Surendra Kumar ^b   Ghosh, Balaram ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 9; CYTOCHROME C OXIDASE; EOTAXIN; ESCULETIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; ANTIASTHMATIC AGENT; ANTIOXIDANT; ARACHIDONATE 15 LIPOXYGENASE; TRANSFORMING GROWTH FACTOR BETA1; UMBELLIFERONE DERIVATIVE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOSOL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; ELECTRON TRANSPORT; ENZYME ACTIVITY; EOSINOPHILIA; EXPERIMENTAL MODEL; INFLAMMATION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL; ANIMAL; ASTHMA; DRUG ANTAGONISM; DRUG EFFECT; FIBROSIS; METABOLISM; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIOXIDANTS; ARACHIDONATE 15-LIPOXYGENASE; ASTHMA; BRONCHIAL HYPERREACTIVITY; ELECTRON TRANSPORT COMPLEX IV; FIBROSIS; MICE; MITOCHONDRIAL DISEASES; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME; UMBELLIFERONES;

EID: 68149138511     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900342     Document Type: Article

References (43)

1. Busse, W. W., and R. F. Lemanske Jr. Asthma. 2001. N. Engl. J. Med. 344: 350-362.
2. Holgate, S. T., D. E. Davies, S. Puddicombe, A. Richter, P. Lackie, J. Lordan, and P. Howarth. 2003. Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma. Eur. Respir. J. 44: 24s-29s.
3. Steinke, J. W., and L. Borish. 2001. Th2 cytokines and asthma: interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir. Res. 2: 66-70.
4. O'Byrne, P. M., and M. D. Inman. 2003. Airway hyperresponsiveness. Chest 123: 411S-416S.
5. Pascual, R. M., and S. P. Peters. 2005. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J. Allergy Clin. Immunol. 116: 477-486.
6. Cohn, L. 2006. Mucus in chronic airway diseases: sorting out the sticky details. J. Clin. Invest. 116: 306-308.
7. Barnes, P. J. 2006. Drugs for asthma. Br. J. Pharmacol. 147: S297-303.
8. Mabalirajan, U., A. K. Dinda, S. Kumar, R. Roshan, P. Gupta, S. K. Sharma, and B. Ghosh. 2008. Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma. J. Immunol. 181: 3540-3548.
9. Fylaktakidou, K. C., D. J. Hadjipavlou-Litina, K. E. Litinas, and D. N. Nicolaides. 2004. Natural and synthetic coumarin derivatives with anti-nflammatory/ antioxidant activities. Curr. Pharm. Des. 10: 3813-3833.
10. Martin-Aragon, S., J. M. Benedi, and A. M. Villar. 1998. Effects of the antioxidant (6,7-dihydroxycoumarin) esculetin on the glutathione system and lipid peroxidation in mice. Gerontology 44: 21-25. (Pubitemid 27526886)
11. Ragazzi, E., G. Froldi, and G. Fassina. 1989. Effects of esculetin (6,7-dihydroxycoumarin) on guinea-pig tracheal chains in vitro. Pharmacol. Res. 21: 183-192. (Pubitemid 19107201)
12. Leung, K. N., P. Y. Leung, L. P. Kong, and P. K. Leung. 2005. Immunomodulatory effects of esculetin (6,7-dihydroxycoumarin) on murine lymphocytes and peritoneal macrophages. Cell. Mol. Immunol. 2: 181-188.
13. Zhao, D. L., L. B. Zou, S. Lin, J. G. Shi, and H. B. Zhu. 2007. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line. Neuropharmacology 53: 724-732.
14. Kuhn, H., J. Belkner, R. Wiesner, and A. R. Brash. 1990. Oxygenation of biological membranes by the pure reticulocyte lipoxygenase. J. Biol. Chem. 265: 18351-18361. (Pubitemid 20382195)
15. Chanez, P., C. Bonnans, C. Chavis, and I. Vachier. 2002. 15-Lipoxygenase: a Janus enzyme? Am. J. Respir. Cell. Mol. Biol. 27: 655-658.
16. Géminard, C., A. de Gassart, and M. Vidal. 2002. Reticulocyte maturation: mitoptosis and exosome release. Biocell 26: 205-215. (Pubitemid 35012805)
17. Kaneko, T., S. Tahara, and F. Takabayashi. 2003. Suppression of lipid hydroperoxide-induced oxidative damage to cellular DNA by esculetin. Biol. Pharm. Bull. 26: 840-844. (Pubitemid 39655305)
18. Lesnefsky, E. J., and C. L. Hoppel. 2008. Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat. Biochim. Biophys. Acta 1777: 1020-1027.
19. Shankaranarayanan, P., and S. Nigam. 2003. IL-4 induces apoptosis in A549 lung adenocarcinoma cells: evidence for the pivotal role of 15-hydroxyeicosatetraenoic acid binding to activated peroxisome proliferator-activated receptor γ transcription factor. J. Immunol. 170: 887-894.
20. Ram, A., U. Mabalirajan, S. K. Singh, V. P. Singh, and B. Ghosh. 2008. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma. Int. Immunopharmacol. 8: 893-899.
21. Ram, A., U. Mabalirajan, M. Das, I. Bhattacharya, A. K. Dinda, S. V. Gangal, and B. Ghosh. 2006. Glycyrrhizin alleviates experimental allergic asthma in mice. Int. Immunopharmacol. 6: 1468-1477.
22. Watanabe, K., A. Ito, T. Sato, T. Saito, H. Hayashi, and Y. Niitani, Y. 1999. Esculetin suppresses proteoglycan metabolism by inhibiting the production of matrix metalloproteinases in rabbit chondrocytes. Eur. J. Pharmacol. 370: 297-305.
23. Steele, V. E., C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman, and G. J. Kelloff. 1999. Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol. Biomarkers Prev. 8: 467-483.
24. Gilani, A. H., K. H. Janbaz, and B. H. Shah. 1998. Esculetin prevents liver damage induced by paracetamol and CCL4. Pharmacol. Res. 37: 31-35.
25. Wood, L. G., P. G. Gibson, and M. L. Garg. 2003. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur. Respir. J. 21: 177-186. (Pubitemid 36150317)
26. Zhu, J., I. Kilty, H. Granger, E. Gamble, Y. S. Qiu, K. Hattotuwa, W. Elston, W. L. Liu, A. Oliva, R. A. Pauwels, et al. 2002. Gene expression and immunolocalization of 15-lipoxygenase isozymes in the airway mucosa of smokers with chronic bronchitis. Am. J. Respir. Cell Mol. Biol. 27: 666-677.
27. Andersson, C. K., H. E. Claesson, K. Rydell-Törmänen, S. Swedmark, A. Hällgren, and J. S. Erjefält. 2008. Mice lacking 12/15-lipoxygenase have attenuated airway allergic inflammation and remodeling. Am. J. Respir. Cell Mol. Biol. 39: 648-656.
28. Hajek, A. R., A. R. Lindley, S. Favoreto, Jr., R. Carter, R. P. Schleimer, and D. A. Kuperman. 2008. 12/15-Lipoxygenase deficiency protects mice from allergic airways Inflammation and increases secretory IgA levels. J. Allergy Clin. Immunol. 122: 633-639.
29. Schewe, T. 2002. 15-Lipoxygenase-1: a prooxidant enzyme. Biol. Chem. 383: 365-374.
30. Cashman, J. R., C. Lambert, and E. Sigal. 1988. Inhibition of human leukocyte 5-lipoxygenase by 15-HPETE and related eicosanoids. Biochem. Biophys. Res. Commun. 155: 38-44.
31. Maurer, I., S. Zierz, and H. J. Möller. 2000. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol. Aging 21: 455-462.
32. Mutisya, E. M., A. C. Bowling, and M. F. Beal. 1994. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63: 2179-2184. (Pubitemid 24369993)
33. Trigulova, V. S. 1978. Cytochrome oxidase activity in diabetes mellitus. Probl. Endokrinol. 24: 14-16.
34. Miró, O., J. R. Alonso, D. Jarreta, J. Casademont, A. Urbano-Márquez, and F. Cardellach. 1999. Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 20: 1331-1336.
35. You, K. R., J. Wen, S. T. Lee, and D. G. Kim. 2002. Cytochrome c oxidase subunit III: a molecular marker for N-(4-hydroxyphenyl)retinamise-induced oxidative stress in hepatoma cells. J. Biol. Chem. 277: 3870-3877.
36. Hong, M. Y., R. S. Chapkin, R. Barhoumi, R C. Burghardt, N. D. Turner, C. E. Henderson, L. M. Sanders, Y. Y. Fan, L. A. Davidson, M. E. Murphy, et al. 2002. Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis 23: 1919-1925.
37. Vendemiale, G., I. Grattagliano, E. Altomare, G. Serviddio, P. Portincasa, F. Prigigallo, and G. Palasciano. 2001. Mitochondrial oxidative damage and myocardial fibrosis in rats chronically intoxicated with moderate doses of ethanol. Toxicol. Lett. 123: 209-216.
38. Masini, A., D. Ceccarelli, F. Giovannini, G. Montosi, C. Garuti, and A. Pietrangelo. 2000. Iron-induced oxidant stress leads to irreversible mitochondrial dysfunctions and fibrosis in the liver of chronic iron-dosed gerbils: the effect of silybin. J. Bioenerg. Biomembr. 32: 175-182.
39. Kim, Y. S., Z. G. Xu, M. A. Reddy, S. L. Li, L. Lanting, K. Sharma, S. G. Adler, and R. Natarajan. 2005. Novel interactions between TGF-β1 actions and the 12/15-lipoxygenase pathway in mesangial cells. J. Am. Soc. Nephrol. 16: 352-362.
40. Pan, S. L., Y. W. Huang, J. H. Guh, Y. L. Chang, C. Y. Peng, and C. M. Teng. 2003. Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats. Biochem. Pharmacol. 65: 1897-1905.
41. Earashi, M., M. Noguchi, K. Kinoshita, and M. Tanaka. 1995. Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Oncology 52: 150-155.
42. Vargaftig, B. B., and M. Singer. 2003. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am. J. Respir. Cell Mol. Biol. 28: 410-419.
43. Zhao, J., B. Maskrey, S. Balzar, K. Chibana, A. Mustovich, H. Hu, J. B. Trudeau, V. O'Donnell, and S. E. Wenzel. 2009. Interleukin-13 induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells. Am. J. Respir. Crit. Care. Med. 179: 782-790.